CGEM
Cullinan Oncology (CGEM)
$34
About Cullinan Oncology (CGEM)
Cullinan Therapeutics, Inc. is a biopharmaceutical company engaged in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.
Details
Daily high
$16.49
Daily low
$16.18
Price at open
$16.36
52 Week High
$30.19
52 Week Low
$7.64
Market cap
947.3M
Dividend yield
0.00%
Volume
227,672
Avg. volume
666,044
P/E ratio
-5.27
Cullinan Oncology News
Details
Daily high
$16.49
Daily low
$16.18
Price at open
$16.36
52 Week High
$30.19
52 Week Low
$7.64
Market cap
947.3M
Dividend yield
0.00%
Volume
227,672
Avg. volume
666,044
P/E ratio
-5.27